Streetbeat News

Price Targets

CLBK

Piper Sandler analyst Mark Fitzgibbon has maintained a Neutral rating on Columbia Financial (NASDAQ:CLBK) and lowered the price target from $18 to $17.5.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 7:07 pm

SEIC

Piper Sandler analyst Sumeet Mody maintains a Neutral rating on SEI Inv (NASDAQ:SEIC) and lowers the price target from $64 to $58.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 7:05 pm

GSHD

Piper Sandler analyst Paul Newsome maintains an Overweight rating on Goosehead Insurance (NASDAQ:GSHD) and raises the price target from $76 to $89.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 7:03 pm

COOP

Piper Sandler analyst Kevin Barker has maintained an Overweight rating on Mr. Cooper Gr (NASDAQ:COOP) and raised the price target from $77 to $79.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:56 pm

CNMD

Piper Sandler analyst Matt O'Brien has maintained an Overweight rating on Conmed (NYSE:CNMD) but lowered the price target from $145 to $130.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:54 pm

CHX

Piper Sandler analyst Luke Lemoine has maintained an Overweight rating on ChampionX (NASDAQ:CHX), but lowered the price target from $42 to $38.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:51 pm

OBT

Piper Sandler analyst Alexander Twerdahl maintains an Overweight rating on Orange County Bancorp (NASDAQ:OBT) and raises the price target from $49 to $51.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:50 pm

ALKS

Piper Sandler analyst David Amsellem has maintained an Overweight rating on Alkermes (NASDAQ:ALKS) but lowered the price target from $37 to $35.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:47 pm

ARQT

Mizuho analyst Uy Ear has downgraded Arcutis Biotherapeutics (NASDAQ:ARQT) from Buy to Neutral and lowered the price target from $57 to $4.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:43 pm

VRT

Mizuho analyst Brett Linzey maintains a Neutral rating on Vertiv Hldgs (NYSE:VRT) and raises the price target from $32 to $39.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:35 pm